Hologic (HOLX) to Expand Surgical Portfolio With Bolder Buyout
Bolder Surgical Holdings Inc. has announced that it has agreed to buy Bolder Surgical for $160 million. The transaction is expected to close before the end of the year. Bolder Surgical manufactures surgical tools and devices used in laparoscopic procedures.
Hologic Inc. (HOLX) recently announced a definitive agreement to acquire Bolder Surgical, a privately-held maker of advanced energy vessel sealing surgical devices. The deal is expected to close by the end of the year. It will add laparoscopic vessel sealing tools to Hologic’s already extensive surgical portfolio. Bolder will also provide Hologic with a new customer base, gynecologists who perform laparoscopic procedures.
The deal allows Hologic to take advantage of Bolder Surgical’s existing channel strength, which will help it accelerate growth. The combined company is planning to launch an expanded Omni suite in EMEA by 2021. It will include the Omni 30deg hysteroscopy system, the Omni Lok cervical seal, and the Omni 5 French seal. These new products will complement the current GYN surgical portfolio and the company’s other products such as the MyoSure tissue removal system and Fluent fluid management systems.
Hologic is a leading medical technology company focusing on women’s health. It has expanded to over 100 countries and holds over 3,000 patents. Its employees are dedicated to providing superior care and improving health outcomes for women.
Hologic Inc. recently announced its plans to grow its surgical portfolio through the acquisition of privately-held Bolder Surgical. Bolder is a provider of advanced energy vessel sealing surgical devices. The acquisition of Bolder will help Hologic diversify its surgical product portfolio and strengthen its growing laparoscopic business. In addition to the acquisition, Hologic recently gave US$5 million to nonprofits in the area of its major facilities.
Hologic recently announced it had entered into a definitive agreement to acquire privately-held Bolder Surgical for $160 million. The deal will add advanced energy vessel sealing devices to Hologic’s surgical portfolio and expand its reach to OB/GYN specialists. The transaction is expected to close by the end of CY21. The company expects the acquisition to be slightly dilutive in FY22, break-even in FY23, and accretive in future years. Bolder’s surgical products will be immediately integrated into Hologic’s portfolio.
Bolder Surgical also offers laparoscopic vessel sealing and dividing tools. The acquisition will increase Hologic’s growth by leveraging its existing channel strength. The new products will help expand the scope of Hologic’s surgical portfolio in the EMEA region. With the addition of Bolder Surgical, Hologic will also expand its existing portfolio by offering new products for pediatric procedures.
Bolder Surgical Holdings Inc.
Bolder Surgical is a developer of surgical instruments and supplies. Its products enable surgeons to perform laparoscopic procedures without having to pause during the procedure. Its products also help surgeons seal blood vessels and dissect tissue without interrupting the procedure. Its acquisition by Hologic will accelerate the company’s growth.
The company recently announced that it had reached a licensing agreement with Intuitive Surgical, a company that makes surgical devices. The deal is expected to close before the end of 2019. The combined company expects to generate sales of up to $500 million by 2019. Hologic is a leader in women’s health and surgical products. It has a market capitalization of $17 billion and more than $5.6 billion in annual revenue. Bolder Surgical began in 2010 as JustRight Surgical LLC but rebranded as a company with a wider focus on the medical market. Its devices include instruments that seal blood vessels and other devices for laparoscopic procedures.
The acquisition will allow Hologic to expand its surgical portfolio to include advanced laparoscopic tools. The company will immediately transition all Bolder Surgical devices into its portfolio.